News and Trends 13 Jul 2015After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its American competitor Depomed. The Irish… July 13, 2015 - 1 minutemin - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jul 2015First-in-human successful Phase I for an Alzheimer’s vaccine AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of patients with Alzheimer’s disease. This… July 10, 2015 - 2 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2015Roche and Evotec knocked down by their Alzheimer candidate The progressive aging of the population in developed countries is turning Alzheimer into one of the biggest medical challenges of… July 2, 2015 - 2 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2015Alkermes presents its new treatment of Alzheimer’s agitation Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and other central nervous system (CNS)… March 4, 2015 - 2 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 18 Feb 2015#BioFigures: 3,000 whole genomes sequenced to fight Parkinson! WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people access, understand and benefit from… February 18, 2015 - 2 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email
News and Trends 11 Feb 2015AB Science: One step further towards a cure to Alzheimer’s disease AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), today announced the… February 11, 2015 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 21 Aug 2014Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first… August 21, 2014 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email